コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tum smear positivity and weight gt 10% below ideal body weight.
2 n of the 12 patients were retested at 90% of ideal body weight.
3 reaching 40 +/- 9 kg/m(2) BMI or 176 +/- 41% ideal body weight.
4 subsequently changed to 400 mg/kg/d based on ideal body weight.
5 on, particularly for patients > or = 130% of ideal body weight.
6 g energy expenditure in subjects 130-159% of ideal body weight.
7 ing to changes in volume of distribution and ideal body weight.
8 All patients were at or above their ideal body weights.
9 99) for extravascular lung water indexed for ideal body weight, 0.97 (0.93-1.01) for spontaneous brea
11 ody surface area (BSA; r2 = 0.277), adjusted ideal body weight (AIBW; r2 = 0.265), and ideal body wei
13 d-expiratory lung volume (30.4 +/- 9.1 mL/kg ideal body weight) and oxygenation (273.4 +/- 72.1 mm Hg
15 ed as a slow 10-mg bolus dose (0.1-0.2 mg/kg ideal body weight), and then an infusion was started at
16 lated on a grams per day, grams per kilogram ideal body weight, and a percentage of calories basis.
17 men who are more physically active, maintain ideal body weight, and consume diets enriched in fruit a
19 greater than 50 years, weight > or = 110% of ideal body weight, and the absence of cytomegalovirus (C
20 corresponding to body weight > or = 120% of ideal body weight, and this figure is rising steadily.
21 nversely with lung function or percentage of ideal body weight, and upper-versus lower-lobe differenc
24 nges in extravascular lung water indexed for ideal body weight could detect weaning-induced pulmonary
26 o receive IV methylprednisolone (15 mg/kg of ideal body weight/day) or IV saline for 3 consecutive da
27 n were more strongly related to actual minus ideal body-weight discrepancy scores (r = 0.77) than to
28 oup consisted of patients who tended towards ideal body weight during the weaning process (BMI 23.9 +
29 face area (BSA), and ideal BSA (derived from ideal body weight for given height) in 970 normotensive
30 calories and ratio were adjusted to maintain ideal body weight for height and maximal urinary ketosis
31 ease in extravascular lung water indexed for ideal body weight greater than or equal to 14% diagnosed
33 ssed as volume (cm3) and as volume per pound ideal body weight (IBW) (cm3/lb) (the conversion factor
35 ent predicted FEV1 was maximal at 90 to 100% ideal body weight (IBW) and was lower as body weight dev
37 with melphalan (M-ILI) dosing corrected for ideal body weight (IBW) is a well-tolerated treatment fo
38 cretion, young age, and low baseline percent ideal body weight (IBW) were each associated with a high
39 d to receive sVLPD or LPD [0.35 or 0.60 g/kg ideal body weight (IBW)/d, respectively], stratified by
40 ed ideal body weight (AIBW; r2 = 0.265), and ideal body weight (IBW; r2 = 0.173); whereas body mass i
41 ion (CFF) recommends using the percentage of ideal body weight (%IBW(CFF)) and body mass index percen
42 elines to eliminate the use of percentage of ideal body weight (%IBW) to define "nutritional failure"
43 t lost (%WL), % excess weight loss (%EWL), % ideal body weight (%IBW), mortality, complications, and
45 the recommended dietary allowance (RDA) for ideal body weight in 1995 among both males and females a
46 d the estimated energy requirement (EER) for ideal body weight in 1995 by 62% for males and 39% for f
47 trial, extravascular lung water indexed for ideal body weight increased only in cases with weaning-i
48 travenous infusion of infliximab, 5 mg/kg of ideal body weight; infusion was repeated at 2 and 6 week
49 y-one healthy, moderately obese (120-140% of ideal body weight, LBW), postmenopausal women (65.6 +/-
50 tes should achieve a BMI <30 kg/m-or percent ideal body weight <140%-before listing for cardiac trans
53 ormotensive African American women > 120% of ideal body weight on the basis of WHRs > 0.85 [upper-bod
55 weight and instead use a consistent weight (ideal body weight or adjusted body weight) when calculat
56 1 ratio, to receive MIRV (6 mg/kg, adjusted ideal body weight) or chemotherapy (paclitaxel, pegylate
59 re, the extravascular lung water indexed for ideal body weight, plasma B-type natriuretic peptide lev
60 ases in extravascular lung water indexed for ideal body weight, plasma protein concentrations, hemogl
61 and ventilator parameters (tidal volume per ideal body weight, positive end-expiratory pressure, and
62 al volume patients: tidal volume 10-12 mL/kg ideal body weight, reduced if inspiratory plateau pressu
64 l or physiologic variable (including percent ideal body weight, serum albumin, prednisone use, lung f
66 2) and weight was 179 +/- 39 kg (270 +/- 51% ideal body weight), significantly greater than in patien
67 ere calculated by using body weight (SUVbw), ideal body weight (SUVibw), lean body mass (SUVlbm), and
68 idal volume patients: tidal volume 5-8 mL/kg ideal body weight, to keep plateau pressure < 30 cm H2O
69 Mechanically ventilated patients (Vt 6 ml/kg ideal body weight) underwent whole-lung computed tomogra
70 viation] vs 31% +/- 7; ie, 32 of 81 mL/kg of ideal body weight vs 27 of 86 mL/kg of ideal body weight